This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $110,000.00 to the University College Dublin (UCD) to investigate the role of the unfolded protein response in clear cell renal cell carcinoma. The goal is to develop novel therapeutic strategies for this disease. UCD, a non-profit educational institution, will conduct academic research and services related to this oncology topic over the 1-year award period from September 1, 2024 to August 31, 2025. As part of its broader federal grant portfolio, UCD has received other prime and subaward funding from the Department of State and Department of Defense to support fellowship programs and academic studies in areas such as COVID-19, cybersecurity, cancer signaling pathways, and HIV.
Generated 2/25/25, 4:53 AM